Stock index futures indicated flat opening as soaring oil prices and disappointing sales of a key drug by Genentech hurt sentiment. The biotechnology company reported higher quarterly profit on strong sales of cancer medicines, but disappointing sales of a drug treating rheumatoid arthritis. Circuit City posted net sales rise of 12.8% on 11.6% increase in comparable store sales. Gannett posted Q1 income dropred to 99 cents a share, in line with expectations. |
More:
